{
  "report_rows": [
    {
      "kpi": "Enterprise revenue",
      "prediction": "BEAT",
      "answer": "pred ~$3.76B vs. cons $3.71B",
      "confidence": "MEDIUM"
    },
    {
      "kpi": "Adjusted EPS",
      "prediction": "BEAT",
      "answer": "pred ~$4.87 vs. cons $4.79",
      "confidence": "MEDIUM"
    },
    {
      "kpi": "BLS quarterly book-to-bill",
      "prediction": "BEAT",
      "answer": "pred ~1.04x vs. cons 1.00x",
      "confidence": "MEDIUM"
    }
  ],
  "guide_rows": [
    {
      "kpi": "FY2026 enterprise revenue guidance",
      "prediction": "BETTER",
      "answer": "guide ~$14.78B vs. cons $14.73B (FY2026)",
      "confidence": "MEDIUM"
    },
    {
      "kpi": "FY2026 adjusted EPS guidance",
      "prediction": "BETTER",
      "answer": "guide ~$18.12 vs. cons $18.03 (FY2026)",
      "confidence": "MEDIUM"
    },
    {
      "kpi": "FY2026 free-cash-flow guidance",
      "prediction": "UNCHANGED",
      "answer": "guide ~$1.30B vs. cons $1.30B (FY2026)",
      "confidence": "MEDIUM"
    }
  ],
  "day1_residual_pct": 3.2,
  "day1_confidence": "MEDIUM",
  "day5_residual_pct": 4.5,
  "day5_path": "FOLLOW-THROUGH",
  "day5_rationale": "A ~$0.09 FY2026 EPS-guide lift versus the current $18.03 midpoint, together with a book-to-bill recovery to ~1.04x versus 1.00x, supports modest upward out-period estimates despite a largely anticipated quarterly beat.",
  "day5_confidence": "MEDIUM"
}